trial · primary record
Selinexor
Primary Myelofibrosis
| Phase | Phase 2 |
|---|---|
| Status | TERMINATED |
| Sponsor | Unknown |
| Enrolment | 17 |
| Primary completion | 2025-03-05 |
| Primary endpoint | Count of Participants With Reduction in Spleen Volume |
| Registry ID | NCT03627403 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:32:19.089Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT03627403
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.